Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-31409.59%
operating margin TTM
-35171.92%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -40.26 |
| peg ratio | -3.38 |
| price to book ratio | 9.73 |
| price to sales ratio | 11,176.21 |
| enterprise value multiple | -36.90 |
| price fair value | 9.73 |
profitability ratios | |
|---|---|
| gross profit margin | 50.0% |
| operating profit margin | -35171.92% |
| pretax profit margin | -31430.82% |
| net profit margin | -31409.59% |
| return on assets | -23.0% |
| return on equity | -31.23% |
| return on capital employed | -26.98% |
liquidity ratios | |
|---|---|
| current ratio | 21.93 |
| quick ratio | 21.93 |
| cash ratio | 6.29 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -51,351.00 |
| cash flow to debt ratio | -53.47 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.40 |
| cash per share | 1.34 |
| operating cash flow per share | -0.30 |
| free cash flow operating cash flow ratio | 1.31 |
| cash flow coverage ratios | -53.47 |
| short term coverage ratios | -148.68 |
| capital expenditure coverage ratio | -3.26 |
Frequently Asked Questions
When was the last time Trevi Therapeutics, Inc. (NASDAQ:TRVI) reported earnings?
Trevi Therapeutics, Inc. (TRVI) published its most recent earnings results on 13-11-2025.
What is Trevi Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Trevi Therapeutics, Inc. (NASDAQ:TRVI)'s trailing twelve months ROE is -31.23%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Trevi Therapeutics, Inc. (TRVI) currently has a ROA of -23.0%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TRVI's net profit margin stand at?
TRVI reported a profit margin of -31409.59% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TRVI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 21.93 in the most recent quarter. The quick ratio stood at 21.93, with a Debt/Eq ratio of 0.00.